The Sepsis Diagnostics Market has emerged as a critical segment within the global healthcare and in-vitro diagnostics industry, driven by the urgent need for early disease detection and improved ...

Canadian scientists have developed a blood test and portable device that can determine the onset of sepsis faster and more accurately than existing methods. Published today in Nature Communications, ...

SAN FRANCISCO and CHICAGO, July 29, 2025 /PRNewswire/ -- New multicenter study data reveals that targeted sepsis testing at triage in the ED may be key to preserving inpatient bed capacity for the ...

The new and rapid culture-free sepsis test identifies pathogens and determines antimicrobial susceptibility in just 13 hours, speeding up sepsis treatment. Blood culture-free ultra-rapid antimicrobial ...

The immune system is generally a pro at fighting off microbial infections. But sometimes it goes rogue, turning itself on the body’s own organs and tissues, resulting in a life-threating condition ...

Dublin, Oct. 16, 2025 (GLOBE NEWSWIRE) -- The "Sepsis Diagnostics Market: 2025 Edition" report has been added to ResearchAndMarkets.com's offering. The global sepsis diagnostics market was valued at ...

(MENAFN- GlobeNewsWire - Nasdaq) The global sepsis diagnostics market, valued at USD 835.40 million in 2023, is projected to reach USD 1.39 billion by 2029, driven by advancements in healthcare ...

The Diagnostics Advisory Committee reviewed the evidence available on the clinical and cost effectiveness of using procalcitonin testing with standard clinical practice to guide antibiotic therapy in ...

LEXINGTON, Mass. - T2 Biosystems, Inc. (NASDAQ:TTOO), has announced the FDA clearance of its T2Candida Panel for use in pediatric patients. The diagnostic test, which detects sepsis-causing Candida ...

The study, being presented tomorrow at the 2025 Association for Diagnostics & Laboratory Medicine (ADLM) Clinical Lab Expo, evaluated 4,650 patients with signs and symptoms of infection tested with ...